Q32 Bio Stock Technical Analysis
| QTTB Stock | 4.01 0.08 2.04% |
As of the 27th of January, Q32 Bio owns the coefficient of variation of 1208.45, and Market Risk Adjusted Performance of (2.46). In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of Q32 Bio, as well as the relationship between them.
Q32 Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Q32, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Q32Q32 Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Q32 Bio Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 15.0 | Buy | 3 | Odds |
Most Q32 analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Q32 stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Q32 Bio, talking to its executives and customers, or listening to Q32 conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Q32 Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Q32 Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Q32 Bio.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Q32 Bio on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Q32 Bio or generate 0.0% return on investment in Q32 Bio over 90 days. Q32 Bio is related to or competes with NextCure, Boundless Bio, SAB Biotherapeutics, AN2 Therapeutics, Verrica Pharmaceuticals, Plus Therapeutics, and Generation Bio. Q32 Bio is entity of United States. It is traded as Stock on NASDAQ exchange. More
Q32 Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Q32 Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Q32 Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.37 | |||
| Information Ratio | 0.075 | |||
| Maximum Drawdown | 85.16 | |||
| Value At Risk | (8.96) | |||
| Potential Upside | 7.51 |
Q32 Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Q32 Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Q32 Bio's standard deviation. In reality, there are many statistical measures that can use Q32 Bio historical prices to predict the future Q32 Bio's volatility.| Risk Adjusted Performance | 0.07 | |||
| Jensen Alpha | 0.8821 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.1235 | |||
| Treynor Ratio | (2.47) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Q32 Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Q32 Bio January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.07 | |||
| Market Risk Adjusted Performance | (2.46) | |||
| Mean Deviation | 5.16 | |||
| Semi Deviation | 5.3 | |||
| Downside Deviation | 6.37 | |||
| Coefficient Of Variation | 1208.45 | |||
| Standard Deviation | 10.48 | |||
| Variance | 109.88 | |||
| Information Ratio | 0.075 | |||
| Jensen Alpha | 0.8821 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.1235 | |||
| Treynor Ratio | (2.47) | |||
| Maximum Drawdown | 85.16 | |||
| Value At Risk | (8.96) | |||
| Potential Upside | 7.51 | |||
| Downside Variance | 40.56 | |||
| Semi Variance | 28.11 | |||
| Expected Short fall | (6.18) | |||
| Skewness | 5.36 | |||
| Kurtosis | 37.95 |
Q32 Bio Backtested Returns
Q32 Bio is very risky given 3 months investment horizon. Q32 Bio retains Efficiency (Sharpe Ratio) of 0.1, which implies the company had a 0.1 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use Q32 Bio market risk adjusted performance of (2.46), and Coefficient Of Variation of 1208.45 to evaluate company specific risk that cannot be diversified away. Q32 Bio holds a performance score of 8 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -0.35, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Q32 Bio are expected to decrease at a much lower rate. During the bear market, Q32 Bio is likely to outperform the market. Use Q32 Bio value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on Q32 Bio.
Auto-correlation | 0.53 |
Modest predictability
Q32 Bio has modest predictability. Overlapping area represents the amount of predictability between Q32 Bio time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Q32 Bio price movement. The serial correlation of 0.53 indicates that about 53.0% of current Q32 Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | 0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Q32 Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Q32 Bio Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Q32 Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Q32 Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Q32 Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Q32 Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Q32 Bio price pattern first instead of the macroeconomic environment surrounding Q32 Bio. By analyzing Q32 Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Q32 Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Q32 Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
Q32 Bio January 27, 2026 Technical Indicators
Most technical analysis of Q32 help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Q32 from various momentum indicators to cycle indicators. When you analyze Q32 charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.07 | |||
| Market Risk Adjusted Performance | (2.46) | |||
| Mean Deviation | 5.16 | |||
| Semi Deviation | 5.3 | |||
| Downside Deviation | 6.37 | |||
| Coefficient Of Variation | 1208.45 | |||
| Standard Deviation | 10.48 | |||
| Variance | 109.88 | |||
| Information Ratio | 0.075 | |||
| Jensen Alpha | 0.8821 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.1235 | |||
| Treynor Ratio | (2.47) | |||
| Maximum Drawdown | 85.16 | |||
| Value At Risk | (8.96) | |||
| Potential Upside | 7.51 | |||
| Downside Variance | 40.56 | |||
| Semi Variance | 28.11 | |||
| Expected Short fall | (6.18) | |||
| Skewness | 5.36 | |||
| Kurtosis | 37.95 |
Q32 Bio January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Q32 stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.02 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 3.97 | ||
| Day Typical Price | 3.98 | ||
| Price Action Indicator | 0.08 | ||
| Market Facilitation Index | 0.08 |
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |